Hovione Launches New Website( LOURES Portugal April 17 /- Hovio...)

LOURES, Portugal, April 17 /PRNewswire/ -- Hovione announced today the launch of its new website http://www.hovione.com. The fully re-designed website provides in-depth and up-to-date information on the Hovione Group.

This updated site reflects Hovione's new business structure organized into four Business Units: Generics, Exclusives, Particle Design and Inhalation. The website is highly informative and comprehensive, however information is easy to find and navigation intuitive.

"The purpose of the re-design is to better reflect our updated offering. Hovione is well known for its portfolio of difficult to make generic APIs, for its long experience in development and synthesis of exclusive APIs for innovators - the new website reflects the fact that we have two new high growth areas: Particle Design and Inhalation Formulation Services," said Guy Villax, Hovione CEO.

Hovione is an international group specializing in the development and compliant manufacture of active pharmaceutical ingredients, serving exclusively the pharmaceutical industry. With sales of US$100 million and a 50-year track record, Hovione offers advanced technologies as well as APIs for all drug delivery systems, from oral to injectable and from inhalation to topical applications. With FDA inspected plants in Europe, the Far East and the US, Hovione is committed to the highest levels of service and quality. Specializing in complex chemistry and in particle engineering, Hovione offers all services related to the development, manufacture and pre-formulation of both new chemical entities (NCEs) and existing APIs for off-patent products.

For further information about Hovione, please visit the Hovione site at http://www.hovione.com or contact Corporate Communications (Isabel Pina, +351-21-982-9362, e-mail: hello@hovione.com).